SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: RCMac who wrote (172)8/28/2002 12:11:34 AM
From: Miljenko Zuanic  Respond to of 447
 
At that time Tarceva was completing PIb fase and CI-1033 was at mid-preclinical stage. Hardly that anyone at FTC can think of those two compounds as serious candidate that may compete one day.

My view is that press overestimated Tarceva antitrust issue, and OSIP endorsed it.

Miljenko